Trials / Conditions / Idiopathic Inflammatory Myositis
Idiopathic Inflammatory Myositis
4 registered clinical trials studyying Idiopathic Inflammatory Myositis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermat NCT05669014 | Amgen | Phase 2 |
| Recruiting | Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank NCT05454527 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD NCT01862926 | Royal Brompton & Harefield NHS Foundation Trust | Phase 2 / Phase 3 |
| Completed | Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum NCT04637672 | Groupe Hospitalier Pitie-Salpetriere | — |